BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 31503049)

  • 1. The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Yoo JS; Patel DS; Hrynewycz NM; Brundage TS; Mogilevsky FA; Singh K
    Clin Spine Surg; 2020 Jul; 33(6):E263-E268. PubMed ID: 31503049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
    Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
    J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
    Adogwa O; Carr K; Thompson P; Hoang K; Darlington T; Perez E; Fatemi P; Gottfried O; Cheng J; Isaacs RE
    World Neurosurg; 2015 May; 83(5):860-6. PubMed ID: 25535070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisions for screw malposition and clinical outcomes after robot-guided lumbar fusion for spondylolisthesis.
    Schröder ML; Staartjes VE
    Neurosurg Focus; 2017 May; 42(5):E12. PubMed ID: 28463610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do measures of surgical effectiveness at 1 year after lumbar spine surgery accurately predict 2-year outcomes?
    Adogwa O; Elsamadicy AA; Han JL; Cheng J; Karikari I; Bagley CA
    J Neurosurg Spine; 2016 Dec; 25(6):689-696. PubMed ID: 26722957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Preoperative 12-Item Short Form Mental Composite Score on Clinical Outcomes in an Isthmic Spondylolisthesis Population Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Patel MR; Jacob KC; Patel SD; Prabhu MC; Vanjani NN; Pawlowski H; Singh K
    World Neurosurg; 2022 Feb; 158():e1022-e1030. PubMed ID: 34906755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.
    Massie LW; Zakaria HM; Schultz LR; Basheer A; Buraimoh MA; Chang V
    Neurosurg Focus; 2018 Jan; 44(1):E8. PubMed ID: 29290133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of the Severity of Preoperative Leg Pain on Patient-Reported Outcomes, Minimum Clinically Important Difference Achievement, and Patient Satisfaction After Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Jacob KC; Patel MR; Collins AP; Parsons AW; Prabhu MC; Vanjani NN; Pawlowski H; Singh K
    World Neurosurg; 2022 Nov; 167():e1196-e1207. PubMed ID: 36075356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the Severity of Preoperative Disability on Patient-Reported Outcomes and Patient Satisfaction Following Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Jacob KC; Patel MR; Collins AP; Ribot MA; Pawlowski H; Prabhu MC; Vanjani NN; Singh K
    World Neurosurg; 2022 Mar; 159():e334-e346. PubMed ID: 34942388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the Preoperative Duration of Symptoms on Patients' Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases.
    Hiranaka Y; Miyazaki S; Yurube T; Kuroshima K; Ryu M; Inoue S; Kakutani K; Tadokoro K
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis.
    Hijji FY; Narain AS; Bohl DD; Yom KH; Kudaravalli KT; Lopez GD; Singh K
    Clin Spine Surg; 2018 Feb; 31(1):E92-E97. PubMed ID: 28538082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Preoperative Back Pain Impact Patient-reported Outcomes in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion for Isthmic Spondylolisthesis?
    Nie JW; Hartman TJ; Zheng E; Oyetayo OO; MacGregor KR; Federico VP; Massel DH; Sayari AJ; Singh K
    Clin Spine Surg; 2024 Jun; 37(5):E179-E184. PubMed ID: 38178316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term durability of minimal invasive posterior transforaminal lumbar interbody fusion: a clinical and radiographic follow-up.
    Rouben D; Casnellie M; Ferguson M
    J Spinal Disord Tech; 2011 Jul; 24(5):288-96. PubMed ID: 20975594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Gender Influence Postoperative Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion?
    Khechen B; Haws BE; Patel DV; Cardinal KL; Guntin JA; Singh K
    Clin Spine Surg; 2019 Mar; 32(2):E107-E111. PubMed ID: 30407263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of minimally invasive transforaminal lumbar interbody fusion and endoscopic lumbar interbody fusion for lumbar degenerative diseases: a retrospective observational study.
    Chen H; Zheng G; Bian Z; Hou C; Li M; Zhang Z; Zhu L; Wang X
    J Orthop Surg Res; 2023 May; 18(1):389. PubMed ID: 37245051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Minimally Invasive Transforaminal Lumbar Interbody Fusion Combined with Gelatin Sponge Impregnated with Dexamethasone and No Drainage Tube after Surgery in the Treatment of Lumbar Degenerative Disease.
    Du JP; Wang XH; Shan LQ; Wang WT; Li HK; Huang DG; Yan L; Hao DJ
    Orthop Surg; 2021 May; 13(3):1077-1085. PubMed ID: 33749136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.
    Parker SL; Adogwa O; Paul AR; Anderson WN; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 May; 14(5):598-604. PubMed ID: 21332281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical outcomes of single-level lumbar spondylolisthesis by minimally invasive transforaminal lumbar interbody fusion with bilateral tubular channels].
    Zeng ZL; Jia L; Yu Y; Xu W; Hu X; Zhan XH; Jia YW; Wang JJ; Cheng LM
    Zhonghua Wai Ke Za Zhi; 2017 Apr; 55(4):279-284. PubMed ID: 28355766
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Preliminary clinical outcomes between percutaneous endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative diseases in a tertiary hospital: Is percutaneous endoscopic procedure superior to MIS-TLIF? A prospective cohort study.
    Ao S; Zheng W; Wu J; Tang Y; Zhang C; Zhou Y; Li C
    Int J Surg; 2020 Apr; 76():136-143. PubMed ID: 32165279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of PROMIS Physical Function in MIS TLIF: 2-Year Follow-up.
    Jenkins NW; Parrish JM; Cha EDK; Lynch CP; Sayari AJ; Geoghegan CE; Jadczak CN; Mohan S; Singh K
    Spine (Phila Pa 1976); 2020 Nov; 45(22):E1516-E1522. PubMed ID: 32756287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.